These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10519261)

  • 1. Summary of the Pneumocystis research presented at the 6th International Workshop on Opportunistic Protists.
    Cushion MT
    J Eukaryot Microbiol; 1999; 46(5):85S-88S. PubMed ID: 10519261
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis 2006: summary of the research presented at the ninth International Workshop on Opportunistic Protists.
    Cushion MT; Smulian AG
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S80-4. PubMed ID: 17169077
    [No Abstract]   [Full Text] [Related]  

  • 3. Are cytochrome b gene mutations the only cause of atovaquone resistance in Pneumocystis?
    Kaneshiro ES
    Drug Resist Updat; 2001 Oct; 4(5):322-9. PubMed ID: 11991686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of pneumocystis research presented at the 8th International Workshop on Opportunistic Protists.
    Limper AH; Merali S
    J Eukaryot Microbiol; 2003; 50 Suppl():602-4. PubMed ID: 14736178
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumocystis jiroveci (formerly Pneumocystis carinii).
    Am J Transplant; 2004 Nov; 4 Suppl 10():135-41. PubMed ID: 15504226
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models.
    Jimenez E; Martínez A; Aliouat el M; Caballero J; Dei-Cas E; Gargallo-Viola D
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2648-50. PubMed ID: 12121948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced pneumocystis carinii activity of new primaquine analogues.
    Goodwin TE; Boylan CJ; Current WL; Byrd JC; Edwards CB; Fuller DA; Green JL; Larocca CD; Raney KD; Ross AS; Tucker WA
    Bioorg Med Chem Lett; 2000 Oct; 10(19):2205-8. PubMed ID: 11012030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A need for standardized definitions for clinical studies of Pneumocystis.
    Miller RF; Huang L
    J Eukaryot Microbiol; 2006; 53 Suppl 1():S87-8. PubMed ID: 17169079
    [No Abstract]   [Full Text] [Related]  

  • 9. High seroprevalence of Pneumocystis infection in Spanish children.
    Respaldiza N; Medrano FJ; Medrano AC; Varela JM; de la Horra C; Montes-Cano M; Ferrer S; Wichmann I; Gargallo-Viola D; Calderon EJ
    Clin Microbiol Infect; 2004 Nov; 10(11):1029-31. PubMed ID: 15522012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis workshop: 10th anniversary summary.
    Beck JM; Cushion MT
    Eukaryot Cell; 2009 Apr; 8(4):446-60. PubMed ID: 19168751
    [No Abstract]   [Full Text] [Related]  

  • 11. Summary of Pneumocystis research presented at the 7th International Workshop on Opportunistic Protists.
    Cushion MT; Beck JM
    J Eukaryot Microbiol; 2001; Suppl():101S-105S. PubMed ID: 11906010
    [No Abstract]   [Full Text] [Related]  

  • 12. Mouse derived Pneumocystis carinii in an axenic culture system.
    Lasbury ME; Goheen MP; Durant PJ; Bartlett MS; Smith JW; Lee CH
    J Eukaryot Microbiol; 1999; 46(5):120S-121S. PubMed ID: 10519277
    [No Abstract]   [Full Text] [Related]  

  • 13. Pneumocystis infection: unraveling the colonization-to-disease shift.
    Calderon EJ; Dei-Cas E
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):259-62. PubMed ID: 20192679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii growth kinetics in culture systems and in hosts: involvement of each life cycle parasite stage.
    Aliouat el-M ; Dujardin L; Martinez A; Duriez T; Ricard I; Dei-Cas E
    J Eukaryot Microbiol; 1999; 46(5):116S-117S. PubMed ID: 10519275
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii.
    Walzer PD; Ashbaugh A; Collins M; Cushion MT
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3234-7. PubMed ID: 11600389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive coexistence of two Pneumocystis species.
    Icenhour CR; Arnold J; Medvedovic M; Cushion MT
    Infect Genet Evol; 2006 May; 6(3):177-86. PubMed ID: 15949973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of Pneumocystis carinii cysts to seed cultures and infect animals.
    Lasbury ME; Goheen MP; Durant PJ; Bartlett MS; Smith JW; Lee CH
    J Eukaryot Microbiol; 1999; 46(5):118S-119S. PubMed ID: 10519276
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumocystis species, co-evolution and pathogenic power.
    Aliouat-Denis CM; Chabé M; Demanche C; Aliouat el M; Viscogliosi E; Guillot J; Delhaes L; Dei-Cas E
    Infect Genet Evol; 2008 Sep; 8(5):708-26. PubMed ID: 18565802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Pneumocystis colonization in families.
    Spencer L; Ukwu M; Alexander T; Valadez K; Liu L; Frederick T; Kovacs A; Morris A
    Clin Infect Dis; 2008 Apr; 46(8):1237-40. PubMed ID: 18444861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.
    O'Neal CB; Ball SC
    AIDS Read; 2008 Oct; 18(10):503-8. PubMed ID: 18975440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.